Hiroshi Yamamoto

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Ryosuke Ochiai, Kentaro Hayashi, Hiroshi Yamamoto, Risa Fujii, Naomi Saichi, Hiroki Shinchi, Tsuyoshi Ishida, Takeshi Honda, Tetsuo Shimizu, Noriyuki Matsutani, Nobuhiko Seki, Masafumi Kawamura, Koji Ueda
Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment. Cancer science 113 (11) (2022)
Hiroshi Yamamoto, Manami Sazuka, Masayuki Ishibashi, Chiemi Nogimori, Kazufumi Takada, Hironobu Hamaya, Hirokazu Yamada, Shuichi Awata
DASC-21: a novel geriatric assessment for discriminating best supportive care in older patients with inoperable advanced non-small cell lung cancer. Japanese journal of clinical oncology 51 (11) (2021)

Hiroshi Yamamoto.css-eqlu8i{font-size:small;padding-left:4px;}